Literature DB >> 11691656

Enhanced tumor necrosis factor-alpha-specific and decreased interleukin-10-specific immune responses to LPS during the third trimester of pregnancy in mice.

E S Vizi1, J Szelényi, Z S Selmeczy, Z Papp, Z H Németh, G Haskó.   

Abstract

It is increasingly apparent that there is a bidirectional interaction between the maternal immune system and the reproductive system during pregnancy. Pregnancy is associated with a suppression of maternal specific immune responses, which process underlies the protection of fetal tissues expressing paternally inherited alloantigens. However, recent evidence indicates that the suppression of specific, lymphocyte-mediated immune responses during pregnancy is accompanied by activation of the non-specific arm of the maternal immune response. In the present study, we have investigated the effect of pregnancy on the non-specific immune response induced by bacterial lipopolysaccharide (LPS, endotoxin) in mice. Pregnancy enhanced the LPS-induced production of proinflammatory cytokines, including tumor necrosis factor-alpha, interleukin (IL)-6, and interferon-gamma. On the other hand, LPS-induced levels of the anti-inflammatory cytokine IL-10 were suppressed in pregnant mice. These alterations in cytokine production correlated with an increased susceptibility for endotoxemic mortality in the pregnant mice. Although adrenergic receptors are important regulators of cytokine production in non-pregnant mice, the alpha(2)- and the beta-adrenoceptor-mediated modulation of cytokine production ceases to operate during pregnancy associated with severe endotoxemia. These data may explain how excessive activation of the non-specific immune responses during pregnancy can contribute to the increased severity of some maternal diseases, including septic shock, and can be an important pathophysiological factor in disseminated intravascular coagulation or preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691656     DOI: 10.1677/joe.0.1710355

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

Review 1.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

2.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

3.  Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt.

Authors:  Jianjun Zhou; Huishuang Miao; Xiujun Li; Yali Hu; Haixiang Sun; Yayi Hou
Journal:  Inflamm Res       Date:  2016-11-05       Impact factor: 4.575

4.  Adaptation of the inflammatory immune response across pregnancy and postpartum in Black and White women.

Authors:  Shannon L Gillespie; Kyle Porter; Lisa M Christian
Journal:  J Reprod Immunol       Date:  2016-02-10       Impact factor: 4.054

5.  Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice.

Authors:  Dongming Lin; Mary Alice Smith; Catherine Champagne; John Elter; James Beck; Steven Offenbacher
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 6.  Review on the impact of pregnancy and obesity on influenza virus infection.

Authors:  Erik A Karlsson; Glendie Marcelin; Richard J Webby; Stacey Schultz-Cherry
Journal:  Influenza Other Respir Viruses       Date:  2012-02-15       Impact factor: 4.380

7.  Severe postpartum sepsis with prolonged myocardial dysfunction: a case report.

Authors:  Michael A Mazzeffi; Katherine T Chen
Journal:  J Med Case Rep       Date:  2010-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.